Standard UTI diagnostics can take up to 72 hours, potentially leaving patients in discomfort and clinicians in a frustrating state of uncertainty. This prolonged wait can fuel treatment errors, drive up hospital visits, and inflate healthcare costs.
Our revolutionary platform combines advanced AI, a proprietary Colorimetric Sensor Array (CSA), and cutting-edge nano-optics to provide real-time insights at the point of care. Sensill aims to empower clinicians with definitive results in minutes, not days.
Our platform is designed for tangible improvements: significantly reduced symptom duration, lower healthcare costs, and fewer repeat visits. For vulnerable populations, particularly pediatric patients, this speed and precision can be even more critical.
By enabling targeted, rapid diagnostics, Sensill aims to play a vital role in the global fight against antibiotic resistance. We aim to help eliminate guesswork, ensuring precise therapy from the very start, protecting both patient health and public health.